The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine

The Effectiveness of Ketamine on Anxiety, Irritability, and Agitation: Implications for Treating Mixed Features in Adults with Major Depressive or Bipolar Disorder

(2020) Roger S. McIntyre et al.   BIPOLAR DISORDERS

The Effectiveness of Repeated Intravenous Ketamine on Depressive Symptoms, Suicidal Ideation and Functional Disability in Adults with Major Depressive Disorder and Bipolar Disorder: Results from the Canadian Rapid Treatment Center of Excellence

(2020) Roger S McIntyre et al.   JOURNAL OF AFFECTIVE DISORDERS

In Vivo Phenotyping, Mechanism‐Informed Treatments, Domain‐Based Psychopathology and Nomological Networks: A Strategy for Treatment Discovery and Development in Bipolar Depression

(2020) Roger S. McIntyre   BIPOLAR DISORDERS

Burden of Treatment Resistant Depression (TRD) in patients with major depressive disorder in Ontario using Institute for Clinical Evaluative Sciences (ICES) databases: Economic burden and healthcare resource utilization

(2020) Roger S. McIntyre et al.   JOURNAL OF AFFECTIVE DISORDERS

A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019

(2020) Walter S. Marcantoni et al.   JOURNAL OF AFFECTIVE DISORDERS

A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression

(2020) Boney Joseph et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Subtypes of treatment-resistant depression determined by a latent class analysis in a Chinese clinical population

(2019) Liwei Liao et al.   JOURNAL OF AFFECTIVE DISORDERS

Have Treatment Studies of Depression Become Even Less Generalizable? Applying the Inclusion and Exclusion Criteria in Placebo-Controlled Antidepressant Efficacy Trials Published over 20 Years to a Clinical Sample

(2019) Mark Zimmerman et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Keeping up with the clinical advances: depression

(2019) Renee-Marie Ragguett et al.   CNS SPECTRUMS

Patient centric measures for a patient centric era: Agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions – Improvement (CGI-S) scale in bipolar and major depressive disorder

(2018) M. Mohebbi et al.   EUROPEAN PSYCHIATRY

Moving from significance to real-world meaning: methods for interpreting change in clinical outcome assessment scores

(2017) Cheryl D. Coon et al.   QUALITY OF LIFE RESEARCH

Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach

(2013) Roger S. McIntyre et al.   JOURNAL OF AFFECTIVE DISORDERS

Treatment-Resistant Depression

(2011) Michael E. Thase   JOURNAL OF CLINICAL PSYCHIATRY

The Clinical Global Impressions scale: errors in understanding and use

(2008) Joan Busner et al.   COMPREHENSIVE PSYCHIATRY

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

(2007) Dennis Revicki et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY